Search research articles
Contact Us
Filters
Showing results (31-40 of 159) with videos related to
Page
of 16
Sort By:
Biomedicines
|
March 28, 2024
Evaluation of the Prognostic Impact of SP263-Evaluated PD-L1 Expression in Patients with Stage III Non-Small Cell Lung Cancer (NSLC) Treated with Radio-Chemotherapy
Jan Nicolai Wagner, Julia Roeper, Lukas Heukamp, et al.
Leukemia & Lymphoma
|
December 29, 2004
AML1/ETO promotes the maintenance of early hematopoietic progenitors in NOD/SCID mice but does not abrogate their lineage specific differentiation
Jörg Bäsecke, Maike Schwieger, Frank Griesinger, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 13, 2012
MO19390 (SAiL): bleeding events in a phase IV study of first-line bevacizumab with chemotherapy in patients with advanced non-squamous NSCLC
Eric Dansin, Saverio Cinieri, Pilar Garrido, et al.
Leukemia & Lymphoma
|
September 17, 2004
B-cell chronic lymphocytic leukemia with aberrant CD8 expression: genetic and immunophenotypic analysis of prognostic factors
Roland Schroers, Tobias Pukrop, Jan Dürig, et al.
BMC Cancer
|
April 2, 2020
Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis
Fränce Hardtstock, David Myers, Tracy Li, et al.
Leukemia Research
|
March 17, 2006
Lifelong persistence of AML associated MLL partial tandem duplications (MLL-PTD) in healthy adults
Jörg Bäsecke, Martina Podleschny, Robert Clemens, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 27, 2019
Efficacy and safety of first-line carboplatin-versus cisplatin-based chemotherapy for non-small cell lung cancer: A meta-analysis
Frank Griesinger, Ellen E Korol, Sheena Kayaniyil, et al.
American Journal of Obstetrics and Gynecology
|
September 19, 2002
Antitumor effects of the cytotoxic luteinizing hormone-releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice
Carsten Gründker, Peter Völker, Frank Griesinger, et al.
Haematologica
|
November 9, 2004
ABC transporter ABCA3 is expressed in acute myeloid leukemia blast cells and participates in vesicular transport
Gerald G Wulf, Simon Modlich, Nobuya Inagaki, et al.
Current Oncology (Toronto, Ont.)
|
September 22, 2022
Acquired G2032R Resistance Mutation in ROS1 to Lorlatinib Therapy Detected with Liquid Biopsy
Balázs Jóri, Markus Falk, Iris Hövel, et al.
Page
of 16
Search research articles
Search
Showing results (31-40 of 159) with videos related to
Sort By:
Page
of 16
Biomedicines
|
March 28, 2024
Evaluation of the Prognostic Impact of SP263-Evaluated PD-L1 Expression in Patients with Stage III Non-Small Cell Lung Cancer (NSLC) Treated with Radio-Chemotherapy
Jan Nicolai Wagner, Julia Roeper, Lukas Heukamp, et al.
Leukemia & Lymphoma
|
December 29, 2004
AML1/ETO promotes the maintenance of early hematopoietic progenitors in NOD/SCID mice but does not abrogate their lineage specific differentiation
Jörg Bäsecke, Maike Schwieger, Frank Griesinger, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 13, 2012
MO19390 (SAiL): bleeding events in a phase IV study of first-line bevacizumab with chemotherapy in patients with advanced non-squamous NSCLC
Eric Dansin, Saverio Cinieri, Pilar Garrido, et al.
Leukemia & Lymphoma
|
September 17, 2004
B-cell chronic lymphocytic leukemia with aberrant CD8 expression: genetic and immunophenotypic analysis of prognostic factors
Roland Schroers, Tobias Pukrop, Jan Dürig, et al.
BMC Cancer
|
April 2, 2020
Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis
Fränce Hardtstock, David Myers, Tracy Li, et al.
Leukemia Research
|
March 17, 2006
Lifelong persistence of AML associated MLL partial tandem duplications (MLL-PTD) in healthy adults
Jörg Bäsecke, Martina Podleschny, Robert Clemens, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 27, 2019
Efficacy and safety of first-line carboplatin-versus cisplatin-based chemotherapy for non-small cell lung cancer: A meta-analysis
Frank Griesinger, Ellen E Korol, Sheena Kayaniyil, et al.
American Journal of Obstetrics and Gynecology
|
September 19, 2002
Antitumor effects of the cytotoxic luteinizing hormone-releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice
Carsten Gründker, Peter Völker, Frank Griesinger, et al.
Haematologica
|
November 9, 2004
ABC transporter ABCA3 is expressed in acute myeloid leukemia blast cells and participates in vesicular transport
Gerald G Wulf, Simon Modlich, Nobuya Inagaki, et al.
Current Oncology (Toronto, Ont.)
|
September 22, 2022
Acquired G2032R Resistance Mutation in ROS1 to Lorlatinib Therapy Detected with Liquid Biopsy
Balázs Jóri, Markus Falk, Iris Hövel, et al.
Page
of 16